01 July 1997
Life-saving therapy with alfa-2b interferon in an infant with Kasabach-Merritt syndrome
Mariusz Wysocki, Ewa Masłowska, Irena Drapińska, Danuta Kurylak, Anna Balcar-BorońMed Sci Monit 1997; 3(4): CS584-588 :: ID: 501439
Abstract
The study describes the case of a male infant with giant hemangioma (localised on the head, neck and upper part of thorax) with highly progressive, life-threatening symptoms of disseminated intravascular coagulation and superior vena cava syndrome. Due to lack of improvement after initial treatment with large doses of corticosteroids and deficient haemostatic factor substitution, we used interferon alfa-2b treatment in everyday doses of 3 mlnU/m2,/day. After a week of treatment, the general condition of the patient improved, the severity of symptoms of superior vena cava syndrome decreased. The hemangioma was progressively decreasing, the haemostasis parameters were returning to normal values (their full normalisation was obtained after 4 months of treatment). In the fifth month, hemangioma transiently increased its diameters and signs of disseminated intravascular coagulation returned, so the dose of interferon was transiently increased. Interferon treatment was applied for the total of 12 months, resulting in very good clinical outcome without major side effects. The case described here confirms that treatment with interferon alfa creates new therapeutic possibilities in situations regarded so far as hopeless.
Keywords: giant hemangioma, Kasabach-Merritt syndrome, treatment, interferon alfa
Editorial
01 April 2025 : Editorial
Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to HumansDOI: 10.12659/MSM.949109
Med Sci Monit 2025; 31:e949109
In Press
Clinical Research
Serum Prolidase and Ischemia-Modified Albumin Levels in Neural Tube Defects: A Comparative Study of Myelome...Med Sci Monit In Press; DOI: 10.12659/MSM.947873
Clinical Research
Impact of Depression, Fatigue, and Pain on Quality of Life in Slovak Multiple Sclerosis PatientsMed Sci Monit In Press; DOI: 10.12659/MSM.947630
Clinical Research
Longitudinal Evaluation of Metabolic Benefits of Inactivated COVID-19 Vaccination in Diabetic Patients in T...Med Sci Monit In Press; DOI: 10.12659/MSM.947450
Clinical Research
Impact of Voltage Level on Hospitalization and Mortality in Electrical Injury Cases: A Retrospective Analys...Med Sci Monit In Press; DOI: 10.12659/MSM.947675
Most Viewed Current Articles
17 Jan 2024 : Review article 8,000,435
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,963
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 30,040
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 23,978
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912